Five reasons coronavirus may be getting less deadly
Covid-19 infection rates are rising in many countries - but death rates remain low
An increase in Covid-19 cases in the UK and many other European countries has triggered fears of a deadly second wave - but another set of statistics offers more grounds for optimism.
“It is becoming increasingly clear that people are less likely to die if they get Covid-19 now compared with earlier in the pandemic, at least in Europe,” says New Scientist.
In the UK, for example, last week’s daily average of 1,060 confirmed new cases per day was the highest since mid-June, but hospital admissions were at their lowest since early March.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“Although hospitalisations and deaths lag infections, neither indicator has shown a corresponding increase even six weeks after the number of cases began to rise,” says the Financial Times.
Here are five possible reasons for the encouraging trend:
1. Different people are catching Covid-19
In the early stages of the pandemic, the coronavirus tore through care homes, infecting vulnerable elderly people.
More recently, that pattern has changed. During June and July, “the share of people diagnosed with coronavirus aged between 18 and 64 increased from a weekly average of 24% to over 40%”, says the FT.
The newspaper suggests that the elderly are now better protected, while younger people, who are unlikely to fall seriously ill, are resuming their normal lives.
That could help explain the shift in infection fatality rates, Oxford University statistician Dr Jason Oke told New Scientist. “Yet Oke doesn’t think the change in age distribution alone is enough to account for what is happening,” the magazine reports.
Many older people are still testing positive, he explains, but more are surviving.
2. More testing
A massive increase in testing is almost certainly a factor: the UK now processes an average about 170,000 tests per day, compared with about 13,000 a day at the start of the outbreak.
“Back in March and April, we were mainly testing people who were really ill and more likely to die,” Paul Hunter, a professor of medicine at the University of East Anglia, told the FT. “Now, the programme is catching a much higher proportion of infections with mild or no symptoms.”
And that could mean the virus looks less deadly while remaining just as fatal. As medical-focused site STAT News explains, “a larger number of diagnosed cases due to more testing would decrease the reported fatality rate”.
3. Better treatments
Statistical questions aside, there is little doubt that more people are now surviving the disease.
“Doctors are getting better at assessing who should go to hospital in the first place, rather than staying at home,” Hunter tells the FT. “When patients are in hospital, clinicians are learning how to treat them more successfully.”
Ventilators are being used more sparingly, with oxygen instead given through less invasive methods. But the biggest advance has been the use of the drug dexamethasone, which has been proven to significantly reduces death rates.
4. A milder strain
Scientists are divided about whether the virus that causes Covid-19 is weaker now than it was in spring.
“Most viruses tend to become less virulent as they mutate,” says Reuters, and some scientists believe the predominant strain now spreading across Europe, known as D614G, is more contagious - but less deadly.
However, “other research disagrees”, says New Scientist. Erik Volz of Imperial College London told the magazine that “we do not see reduced risk of death due to the D614G variant”.
5. Smaller doses
“The more virus you get into your body, the more sick you are likely to get,” says Monica Gandhi, an infectious disease expert at the University of California, San Francisco.
The result of post-lockdown changes in society - with more people wearing masks, washing their hands more often, and avoiding physical contact with others - may therefore lead to milder infections.
Or as The Guardian puts it, “infectious doses of the Covid-19 virus, transmitted from one person to another, may be getting smaller thanks to social distancing”.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Holden Frith is The Week’s digital director. He also makes regular appearances on “The Week Unwrapped”, speaking about subjects as diverse as vaccine development and bionic bomb-sniffing locusts. He joined The Week in 2013, spending five years editing the magazine’s website. Before that, he was deputy digital editor at The Sunday Times. He has also been TheTimes.co.uk’s technology editor and the launch editor of Wired magazine’s UK website. Holden has worked in journalism for nearly two decades, having started his professional career while completing an English literature degree at Cambridge University. He followed that with a master’s degree in journalism from Northwestern University in Chicago. A keen photographer, he also writes travel features whenever he gets the chance.
-
Today's political cartoons - December 21, 2024
Cartoons Saturday's cartoons - losing it, pedal to the metal, and more
By The Week US Published
-
Three fun, festive activities to make the magic happen this Christmas Day
Inspire your children to help set the table, stage a pantomime and write thank-you letters this Christmas!
By The Week Junior Published
-
The best books of 2024 to give this Christmas
The Week Recommends From Percival Everett to Rachel Clarke these are the critics' favourite books from 2024
By The Week UK Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published